Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant

References

• Shah RR, Hassett KJ, Brito LA. Overview of Vaccine Adjuvants: Introduction, History, and Current Status. Methods Mol Biol. 2017;1494:1–13. doi:10.1007/978-1-4939-6445-1_1.
   PubMedGoogle Scholar
• Andersen P, Urdahl KB. TB vaccines; promoting rapid and durable protection in the lung. Curr Opin Immunol. 2015;35:55–62. doi:10.1016/j.coi.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Liang J, Zhang Y, Teng X, Yuan X, Fan X. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-gamma+ IL-2+ CD4+ and IFN-gamma+ CD8+ T cells. PLoS One. 2015;10:e0122560. doi:10.1371/journal.pone.0122560.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang E, Huang Q, Ni W, Kong C, Liu G, Li G, Su H, Wang H. PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2. J Mol Med (Berl). 2015;93:645–62. doi:10.1007/s00109-014-1243-1.
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J Immunol. 2009;183:6883–92. doi:10.4049/jimmunol.0901466.
   PubMed Web of Science ®Google Scholar
• Salem AK. Nanoparticles in vaccine delivery. AAPS J. 2015;17:289–91. doi:10.1208/s12248-015-9720-1.
   PubMed Web of Science ®Google Scholar
• Branquinho LC, Carriao MS, Costa AS, Zufelato N, Sousa MH, Miotto R, Ivkov R, Bakuzis AF. Effect of magnetic dipolar interactions on nanoparticle heating efficiency: implications for cancer hyperthermia. Sci Rep. 2013;3:2887. doi:10.1038/srep02887.
   PubMed Web of Science ®Google Scholar
• Ludwig F, Eberbeck D, Lowa N, Steinhoff U, Wawrzik T, Schilling M, Trahms L. Characterization of magnetic nanoparticle systems with respect to their magnetic particle imaging performance. Biomed Tech (Berl). 2013;58:535–45. doi:10.1515/bmt-2013-0013.
   PubMed Web of Science ®Google Scholar
• Hola K, Markova Z, Zoppellaro G, Tucek J, Zboril R. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances. Biotechnol Adv. 2015;33:1162–76. doi:10.1016/j.biotechadv.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Quini CC, Prospero AG, Calabresi MFF, Moretto GM, Zufelato N, Krishnan S, Pina DR, Oliveira RB, Baffa O, Bakuzis AF, et al. Real-time liver uptake and biodistribution of magnetic nanoparticles determined by AC biosusceptometry. Nanomedicine. 2017;13:1519–29. doi:10.1016/j.nano.2017.02.005.
   PubMed Web of Science ®Google Scholar
• Fang RH, Zhang L. Nanoparticle-Based Modulation of the Immune System. Annu Rev Chem Biomol Eng. 2016;7:305–26. doi:10.1146/annurev-chembioeng-080615-034446.
   PubMed Web of Science ®Google Scholar
• Marques Neto LM, Kipnis A, Junqueira-Kipnis AP. Role of metallic nanoparticles in vaccinology: Implications for infectious disease vaccine development. Front Immunol. 2017;8:239. doi:10.3389/fimmu.2017.00239.
   PubMed Web of Science ®Google Scholar
• Pusic K, Aguilar Z, McLoughlin J, Kobuch S, Xu H, Tsang M, Wang A, Hui G. Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine. FASEB J. 2013;27:1153–66. doi:10.1096/fj.12-218362.
   PubMed Web of Science ®Google Scholar
• Zumla A, George A, Sharma V, Herbert RH, Baroness Masham of I, Oxley A, Oliver M. The WHO 2014 global tuberculosis report–further to go. Lancet Glob Health. 2015;3:e10–2. doi:10.1016/S2214-109X(14)70361-4.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Weiner J, von Reyn CF. Novel approaches to tuberculosis vaccine development. Int J Infect Dis. 2017;56:263–7. doi:10.1016/j.ijid.2016.10.018.
   PubMed Web of Science ®Google Scholar
• Warrier T, Tropis M, Werngren J, Diehl A, Gengenbacher M, Schlegel B, Schade M, Oschkinat H, Daffe M, Hoffner S, et al. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis. Antimicrob Agents Chemother. 2012;56:1735–43. doi:10.1128/AAC.05742-11.
   PubMed Web of Science ®Google Scholar
• Rinke de Wit TF, Bekelie S, Osland A, Wieles B, Janson AA, Thole JE. The Mycobacterium leprae antigen 85 complex gene family: identification of the genes for the 85A, 85C, and related MPT51 proteins. Infect Immun. 1993;61:3642–7.
   PubMed Web of Science ®Google Scholar
• Ramalingam B, Baulard AR, Locht C, Narayanan PR, Raja A. Cloning, expression, and purification of the 27 kDa (MPT51, Rv3803c) protein of Mycobacterium tuberculosis. Protein Expr Purif. 2004;36:53–60. doi:10.1016/j.pep.2004.01.016.
   PubMed Web of Science ®Google Scholar
• Haile Y, Bjune G, Wiker HG. Expression of the mceA, esat-6 and hspX genes in Mycobacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply. Microbiology. 2002;148:3881–6. doi:10.1099/00221287-148-12-3881.
   PubMed Web of Science ®Google Scholar
• Hu Y, Movahedzadeh F, Stoker NG, Coates AR. Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun. 2006;74:861–8. doi:10.1128/IAI.74.2.861-868.2006.
   PubMed Web of Science ®Google Scholar
• de Sousa EM, da Costa AC, Trentini MM, de Araujo Filho JA, Kipnis A, Junqueira-Kipnis AP. Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection. PLoS One. 2012;7:e47781. doi:10.1371/journal.pone.0047781.
   PubMed Web of Science ®Google Scholar
• Junqueira-Kipnis AP, de Oliveira FM, Trentini MM, Tiwari S, Chen B, Resende DP, Silva BD, Chen M, Tesfa L, Jacobs WR, Jr, et al. Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis. PLoS One. 2013;8:e78639. doi:10.1371/journal.pone.0078639.
   PubMed Web of Science ®Google Scholar
• da Costa AC, Costa-Junior Ade O, de Oliveira FM, Nogueira SV, Rosa JD, Resende DP, Kipnis A, Junqueira-Kipnis AP. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis. PLoS One. 2014;9:e112848. doi:10.1371/journal.pone.0112848.
   PubMed Web of Science ®Google Scholar
• Oliveira FM, Trentini MM, Junqueira-Kipnis AP, Kipnis A. The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guerin but with similar lung inflammatory effects. Mem Inst Oswaldo Cruz. 2016;111:223–31. doi:10.1590/0074-02760150411.
   PubMed Web of Science ®Google Scholar
• da Costa AC, de Resende DP, Santos BPO, Zoccal KF, Faccioli LH, Kipnis A, Junqueira-Kipnis AP. Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis. Front Microbiol. 2017;8:623.
   PubMed Web of Science ®Google Scholar
• Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med. 2013;210:1855–69. doi:10.1084/jem.20130091.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang J, Zganiacz A, Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun. 2004;72:238–46. doi:10.1128/IAI.72.1.238-246.2004.
   PubMed Web of Science ®Google Scholar
• Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S, Blanchard JL, Didier PJ, Roy CJ, Rao SS, et al. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge. J Immunol. 2014;193:1799–811. doi:10.4049/jimmunol.1400676.
   PubMed Web of Science ®Google Scholar
• Orr MT, Beebe EA, Hudson TE, Argilla D, Huang PW, Reese VA, Fox CB, Reed SG, Coler RN. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Vaccine. 2015;33:6570–8. doi:10.1016/j.vaccine.2015.10.115.
   PubMed Web of Science ®Google Scholar
• Trentini MM, de Oliveira FM, Kipnis A, Junqueira-Kipnis AP. The role of neutrophils in the induction of specific Th1 and Th17 during vaccination against tuberculosis. Front Microbiol. 2016;7:898. doi:10.3389/fmicb.2016.00898.
   PubMed Web of Science ®Google Scholar
• Monin L, Griffiths KL, Slight S, Lin Y, Rangel-Moreno J, Khader SA. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge. Mucosal Immunol. 2015;8:1099–109. doi:10.1038/mi.2014.136.
   PubMed Web of Science ®Google Scholar
• Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA. Intranasal immunization promotes th17 immune responses. J Immunol. 2009;183:6933–8. doi:10.4049/jimmunol.0901144.
   PubMed Web of Science ®Google Scholar
• Wern JE, Sorensen MR, Olsen AW, Andersen P, Follmann F. Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract. Front Immunol. 2017;8:569. doi:10.3389/fimmu.2017.00569.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Del Rio E, Marradi M, Calderon-Gonzalez R, Frande-Cabanes E, Penades S, Petrovsky N, Alvarez-Dominguez C. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax delta inulin adjuvant induces robust T-cell protection against listeria infection. Vaccine. 2015;33:1465–73. doi:10.1016/j.vaccine.2015.01.062.
   PubMed Web of Science ®Google Scholar
• Niikura K, Matsunaga T, Suzuki T, Kobayashi S, Yamaguchi H, Orba Y, Kawaguchi A, Hasegawa H, Kajino K, Ninomiya T, et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano. 2013;7:3926–38. doi:10.1021/nn3057005.
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Kumar A, Cui ZR. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Exp Rev Vaccines. 2010;9:1095–107. doi:10.1586/erv.10.89.
   PubMed Web of Science ®Google Scholar
• Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. European J Immunol. 2008;38:1404–13. doi:10.1002/eji.200737984.
   PubMed Web of Science ®Google Scholar
• Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrom T, Agger EM, Andersen P, et al. Comparison of the Depot Effect and Immunogenicity of Liposomes Based on Dimethyldioctadecylammonium (DDA), 3 beta[N ‘,N ’-Dimethylaminoethane)carbomyl] Cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium Propane (DOTAP): Prolonged Liposome Retention Mediates Stronger Th1 responses. Mol Pharmaceutics. 2011;8:153–61. doi:10.1021/mp100208f.
   PubMed Web of Science ®Google Scholar
• Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121:985–97. doi:10.1172/JCI44490.
   PubMed Web of Science ®Google Scholar
• Filipov NM, Seegal RF, Lawrence DA. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicological Sci. 2005;84:139–48. doi:10.1093/toxsci/kfi055.
   PubMed Web of Science ®Google Scholar
• Apte SH, Redmond AM, Groves PL, Schussek S, Pattinson DJ, Doolan DL. Subcutaneous cholera toxin exposure induces potent CD103(+) dermal dendritic cell activation and migration. Eur J Immunol. 2013;43:2707–17. doi:10.1002/eji.201343475.
   PubMed Web of Science ®Google Scholar
• del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Forster R. Development and functional specialization of CD103+ dendritic cells. Immunol Rev. 2010;234:268–81. doi:10.1111/j.0105-2896.2009.00874.x.
   PubMed Web of Science ®Google Scholar
• Felton C, Karmakar A, Gartia Y, Ramidi P, Biris AS, Ghosh A. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles. Drug Metab Rev. 2014;46:142–54. doi:10.3109/03602532.2013.876429.
   PubMed Web of Science ®Google Scholar
• Nunes ADC, Ramalho LS, Souza APS, Mendes EP, Colugnati DB, Zufelato N, Sousa MH, Bakuzis AF, Castro CH. Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects. Int J Nanomed. 2014;9:3299–312.
   PubMed Web of Science ®Google Scholar
• Prospero AG, Quini CC, Bakuzis AF, Fidelis-de-Oliveira P, Moretto GM, Mello FPF, Calabresi MF, Matos RV, Zandoná EA, Zufelato N, et al. Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry. J Nanobiotechnol. 2017;15:22. doi:10.1186/s12951-017-0257-6.
   PubMed Web of Science ®Google Scholar
• Mokgobu MI, Anderson R, Steel HC, Cholo MC, Tintinger GR, Theron AJ. Manganese promotes increased formation of hydrogen peroxide by activated human macrophages and neutrophils in vitro. Inhalation Toxicol. 2012;24:634–44. doi:10.3109/08958378.2012.706657.
   PubMed Web of Science ®Google Scholar
• Dorman DC, Struve MF, James RA, Marshall MW, Parkinson CU, Wong BA. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure. Toxicol Appl Pharmacol. 2001;170:79–87. doi:10.1006/taap.2000.9088.
   PubMed Web of Science ®Google Scholar
• Park EJ, Oh SY, Lee SJ, Lee K, Kim Y, Lee BS, Kim JS. Chronic pulmonary accumulation of iron oxide nanoparticles induced Th1-type immune response stimulating the function of antigen-presenting cells. Environ Res. 2015;143:138–47. doi:10.1016/j.envres.2015.09.030.
   PubMed Web of Science ®Google Scholar
• Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R. Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromol Med. 2009;11:252–66. doi:10.1007/s12017-009-8083-0.
   PubMed Web of Science ®Google Scholar
• Moschos SA, Bramwell VW, Somavarapu S, Alpar HO. Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunol Cell Biol. 2004;82:628–37. doi:10.1111/j.0818-9641.2004.01280.x.
   PubMed Web of Science ®Google Scholar
• Tran KK, Shen H. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells. Biomaterials. 2009;30:1356–62. doi:10.1016/j.biomaterials.2008.11.034.
   PubMed Web of Science ®Google Scholar
• Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol. 2015;37:239–49. doi:10.1007/s00281-015-0490-8.
   PubMed Web of Science ®Google Scholar
• Ekkens MJ, Shedlock DJ, Jung E, Troy A, Pearce EL, Shen H, Pearce EJ. Th1 and Th2 cells help CD8 T-cell responses. Infect Immun. 2007;75:2291–6. doi:10.1128/IAI.01328-06.
   PubMed Web of Science ®Google Scholar
• Tamburini BA, Burchill MA, Kedl RM. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat Communications. 2014;5:3989. doi:10.1038/ncomms4989.
   PubMed Web of Science ®Google Scholar
• de Paula Oliveira Santos B, Trentini MM, Machado RB, Rubia Nunes Celes M, Kipnis A, Petrovsky N, Junqueira-Kipnis AP. Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of three protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection. Hum Vaccin Immunother. 2017;13(12):2967–76. doi:10.1080/21645515.2017.1368598.
   PubMed Web of Science ®Google Scholar
• Comoy EE, Capron A, Thyphronitis G. In vivo induction of type 1 and 2 immune responses against protein antigens. Int Immunol. 1997;9:523–31. doi:10.1093/intimm/9.4.523.
   PubMed Web of Science ®Google Scholar
• Zenaro E, Donini M, Dusi S. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN. J Leukoc Biol. 2009;86:1393–401. doi:10.1189/jlb.0409242.
   PubMed Web of Science ®Google Scholar
• Grosse S, Stenvik J, Nilsen AM. Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes. Int J Nanomed. 2016;11:4625–42. doi:10.2147/IJN.S113425.
   PubMed Web of Science ®Google Scholar
• Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32:3623–9. doi:10.1016/j.vaccine.2014.04.085.
   PubMed Web of Science ®Google Scholar
• Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126:656–64. doi:10.1542/peds.2010-0309.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–51. doi:10.1038/nbt.3330.
   PubMed Web of Science ®Google Scholar
• Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13:125–38. doi:10.1038/nmat3780.
   PubMed Web of Science ®Google Scholar
• Southern P, Pankhurst QA. Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models. Int J Hyperther. 2017;1–16. doi:10.1080/02656736.2017.1365953.
   PubMed Web of Science ®Google Scholar
• Mazuel F, Espinosa A, Luciani N, Reffay M, Le Borgne R, Motte L, Desboeufs K, Michel A, Pellegrino T, Lalatonne Y, et al. Massive intracellular biodegradation of iron oxide nanoparticles evidenced magnetically at single-endosome and tissue levels. ACS Nano. 2016;10:7627–38. doi:10.1021/acsnano.6b02876.
   PubMed Web of Science ®Google Scholar
• Gabbasov R, Cherepanov V, Chuev M, Polikarpov M, Nikitin M, Deyev S, Panchenko V. Biodegradation of Magnetic Nanoparticles in Mouse Liver From Combined Analysis of Mössbauer and Magnetization Data. IEEE Trans. Magn. 2012;49:394–7. doi:10.1109/TMAG.2012.2226148.
   Web of Science ®Google Scholar
• Lopez Y, Yero D, Falero-Diaz G, Olivares N, Sarmiento ME, Sifontes S, Solis RL, Barrios JA, Aguilar D, Hernández-Pando R, et al. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection. Int J Med Microbiol. 2009;299:447–52. doi:10.1016/j.ijmm.2008.10.007.
   PubMed Web of Science ®Google Scholar
• Hamasur B, Haile M, Pawlowski A, Schroder U, Kallenius G, Svenson SB. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol. 2004;138:30–8. doi:10.1111/j.1365-2249.2004.02593.x.
   PubMed Web of Science ®Google Scholar
• Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev. 2015;264:167–81. doi:10.1111/imr.12276.
   PubMed Web of Science ®Google Scholar
• Kumar S, Anselmo AC, Banerjee A, Zakrewsky M, Mitragotri S. Shape and size-dependent immune response to antigen-carrying nanoparticles. J Control Release. 2015;220:141–8. doi:10.1016/j.jconrel.2015.09.069.
   PubMed Web of Science ®Google Scholar
• Fromen CA, Robbins GR, Shen TW, Kai MP, Ting JP, DeSimone JM. Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization. Proc Natl Acad Sci U S A. 2015;112:488–93. doi:10.1073/pnas.1422923112.
   PubMed Web of Science ®Google Scholar
• Turner DL, Bickham KL, Thome JJ, Kim CY, D'Ovidio F, Wherry EJ, et al. Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol. 2014;7:501–10. doi:10.1038/mi.2013.67.
   PubMed Web of Science ®Google Scholar
• Cardona PJ, Cooper A, Luquin M, Ariza A, Filipo F, Orme IM, et al. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol. 1999;49:362–6. doi:10.1046/j.1365-3083.1999.00522.x.
   PubMed Web of Science ®Google Scholar
• Yang YK, Burkhard P. Encapsulation of gold nanoparticles into self-assembling protein nanoparticles. J Nanobiotechnol. 2012;10:42. doi:10.1186/1477-3155-10-42.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5. doi:10.1038/nmeth.2089.
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7:779–86. doi:10.1038/nnano.2012.207.
   PubMed Web of Science ®Google Scholar